Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction

NCT02564367 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma,Stomach
Adenocarcinoma, Esophagogastric Junction

Interventions

DRUG: S-1

Sponsor

AIO-Studien-gGmbH

Collaborators

[object Object]
[object Object]